Dr. Víctor Andrés Arrieta from the Department of Neurosurgery at Northwestern University Feinberg School of Medicine answers questions from a recent webinar discussing the relationship between p-ERK activation and enhanced survival outcomes in rGBM patients undergoing anti-PD-1 immunotherapy.